Vijay Salvekar

macrolides chloramphenicol fluoroquinolones mechanism of action yellow card blue card adverse drug reaction clinical trials thalidomide disaster who prevention understanding assessment detection pharmacovigilance stirrup hammer anvil ear drum semicircular canal cranial nerve vestibule cochlea eustachian tube round window oval window stapes incus malleus tympanic membrane external auditory canal inner middle outer the_human_ear epinephrine tyrosine antihistaminics amantadine tolcapone entacapone rasagiline selegiline comt inhibitor mao-b inhibitor ropinirole bromocriptyne benserazid carbidopa levodopa antiparkinson drug mesolimbic pathway nigrostriatal pathway epinephrine histamine serotoni dopamine norepinephri gases lipids purines neuropeptides amino acids aspartate glutamate glycine gaba amino acids norepinephrine dopamine atecholamines histamine monoamines - acetylcholine hallucinogens and testes. ovaries pancreas thyroid gland adrenal glands pitutory glans growth hormone steroids amino acid hormones endocrine system addiction drugs abuse cns stimulents anesthetic classifications action potential local anesthetics myasthenia gravis skeletal muscle relaxants peripherally acting saddle gliding pivot condyloid hinge skeletal system joints quinolones dna gyrase inhibitors enzyme-linked receptors g-protein linked receptors ion channels metabotropic inotropic receptor classification receptors anticonvulsants anti-epileptic drugs body cavities body plans basic anatomical terminology basic life process homeostatic mechanism scope anatomy and physiology anti-alzheimers drug anti-anxity drugs blood clotting blood grouping hematopoietic system-human blood neurtransmeter neuron details about various routes for drug administrati routes of drug adminstration factors for the choi troduction to pharmacology defination scope histor endogenous agonist super agonist full agonist part agonists and antagonists ligands types of agonist eries: efferent vessels capillaries: veins: affere actinomycin amphotericine b. 4. inhibitors of nucleic acid nystatin lincosamide 3. inhibitors of bacterial cell memb tertacycline cycloserine 2. inhibitors of protien synthesis: bacitaeacin cephalosporine alexander fleming microbes make antibiotics e other inflammatory bowel disease sulfasalaz enteritis gi infections (2) intestinal infections ulc respiratory infections 1.systemic infections cerebral meningitis tympani pharmacokinetics clinical uses long acting (> 12 hrs) sulphadoxine - sulphameth penetrates bbb- meningitis acetylated product is systemic use i.short acting (4-8hrs) sulpha me and some protozoa. sulphonamides (members) chlamydia trachomatis nocardia actinomyces shigella others: bacillus anthracis escherichia coli gonococcus g+ bacteria: group a streptococcus pyogenes str broad-spectrum trimethoprim (cotrimoxazole) as antibacterial pyri the development of chemotherapy tetracyclines sulphonamides quinolones (gaba antagonists) molecular basis of chemotherapy mechanisms of action of antibacterial drugs drugs that inhibit nucleic acid synthesis nucleosi biochemical reaction as potent targets basic principles of chemotherapy antiviral drugs antimicrobial drugs antibacterials – competitive inhibitors aminoglycosides gatifloxacin lomefloxacin and pefloxacin enoxacin ofloxacin levofloxacin ciprofloxacin norfloxacin generations topoisomerases bactericidal adverse effects clinical uses pharmacokinetics mechanisms of resistance classifications antimicrobial activity its structure na gyrase inhibitors -quinolones β -lactam antibiotics classification cephalosporins and development human heart covering layers and wall human heart conduction system human heart basic functions human heart anatomy and physiology